Latest News

Drug Regulatory Authority of Pakistan notifies new rules for pharma marketing and doctors

DRAP has notified that the pharmaceutical companies will not bear the travel expenses of the family and other members of doctors.

Drug Regulatory Authority of PakistanDrug Regulatory Authority of Pakistan notifies new rules | OyeYeah News
Views

Drug Regulatory Authority of Pakistan (DRAP) has notified new rules for pharma marketing and doctors on Saturday.

After getting approval from the Federal government, DRAP has notified that the pharmaceutical companies will not bear the travel expenses of the family and other members of doctors.

Meanwhile, doctors will not be given the costs of foreign travel without getting issued a No objection certificate (NOC) from their respective institution, stated in the DRAP notification.

The notification further stated that for educational and scientific conferences, unnecessary payments should not be paid to doctors, while the given amount will be calculated.

For the implications of new rules, DRAP has directed the pharmaceutical companies to appoint senior officers.

DRAP has also directed the pharmaceutical companies to provide details of expenditure on doctors and medical organizations.

As per the new directives:
The DRAP has prohibited the pharmaceutical companies from providing money for recreational tours and expensive residency.

DRAP prohibited providing the doctors with expensive food and amusement activities. While the authority also orders to discontinue all recreational activities for doctors’ families.

DRAP also prohibited providing the doctor with any kind of gift.

the authorSaman Siddiqui
Saman Siddiqui, A freelance journalist with a Master’s Degree in Mass Communication and MS in Peace and Conflict Studies. Associated with the media industry since 2006. Experience in various capacities including Program Host, Researcher, News Producer, Documentary Making, Voice Over, Content Writing Copy Editing, and Blogging, and currently associated with OyeYeah since 2018, working as an Editor.